Cargando…
Targeting the Bromodomain of BRG-1/BRM Subunit of the SWI/SNF Complex Increases the Anticancer Activity of Temozolomide in Glioblastoma
Glioblastoma (GBM) is a deadly and incurable brain cancer with limited therapeutic options. PFI-3 is a small-molecule bromodomain (BRD) inhibitor of the BRM/BRG1 subunits of the SWI/SNF chromatin remodeling complex. The objective of this study is to determine the efficacy of PFI-3 as a potential GBM...
Autores principales: | Yang, Chuanhe, Wang, Yinan, Sims, Michelle M., He, Yali, Miller, Duane D., Pfeffer, Lawrence M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467157/ https://www.ncbi.nlm.nih.gov/pubmed/34577604 http://dx.doi.org/10.3390/ph14090904 |
Ejemplares similares
-
Next‐generation bromodomain inhibitors of the SWI/SNF complex enhance DNA damage and cell death in glioblastoma
por: Yang, Chuanhe, et al.
Publicado: (2023) -
Antagonistic Roles for BRM and BRG1 SWI/SNF Complexes in
Differentiation
por: Flowers, Stephen, et al.
Publicado: (2009) -
Loss of the SWI/SNF ATPase subunits BRM and BRG1 drives lung cancer development
por: Marquez-Vilendrer, Stefanie B., et al.
Publicado: (2016) -
The silencing of the SWI/SNF subunit and anticancer gene BRM in Rhabdoid tumors
por: Kahali, Bhaskar, et al.
Publicado: (2014) -
Co-regulation of transcription by BRG1 and BRM, two mutually exclusive SWI/SNF ATPase subunits
por: Raab, Jesse R., et al.
Publicado: (2017)